Beijing Friendship Hospital
Clinical trials sponsored by Beijing Friendship Hospital, explained in plain language.
-
New surgical strategy aims to spare stomach function in cancer patients
Disease control Recruiting nowThis study is testing a more precise surgical technique for early stomach cancer. It uses a fluorescent dye during surgery to identify and remove only the key lymph nodes that cancer might spread to, instead of removing many lymph nodes by default. The goal is to preserve more of…
Phase: NA • Sponsor: Beijing Friendship Hospital • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New drug duo teams up with chemo to fight advanced stomach cancer
Disease control Recruiting nowThis study is testing whether adding a new two-drug immunotherapy (called QL1706) to standard chemotherapy works better for people with advanced stomach or gastroesophageal junction cancer who haven't had prior treatment. About 32 participants will receive the combination therapy…
Phase: PHASE2 • Sponsor: Beijing Friendship Hospital • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Four-Drug attack aims to shrink inoperable stomach tumors for surgery
Disease control Recruiting nowThis study is testing whether a combination of four medications can shrink advanced stomach or gastroesophageal junction cancer tumors enough to make surgery possible. The treatment includes immunotherapy, targeted therapy, and chemotherapy given in cycles before a planned operat…
Phase: PHASE2 • Sponsor: Beijing Friendship Hospital • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Lab-Grown liver cells tested as life support for failing livers
Disease control Recruiting nowThis early-stage study is testing a new bioartificial liver device in 12 patients with severe liver failure. The main goal is to see if the treatment is safe and well-tolerated. Researchers will also look for early signs that it might help support or improve the patient's own liv…
Phase: PHASE1, PHASE2 • Sponsor: Beijing Friendship Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New hope for rectal cancer: adding immunotherapy to standard treatment
Disease control Recruiting nowThis study is testing if adding an immunotherapy drug (tislelizumab) to standard chemotherapy and radiation before surgery works better for people with locally advanced rectal cancer. It will compare the new combination against the standard treatment alone in about 375 participan…
Phase: PHASE2, PHASE3 • Sponsor: Beijing Friendship Hospital • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
New drug duo targets persistent 'Mono' virus in adults
Disease control Recruiting nowThis study is testing whether a combination of two drugs, golidocitinib and selinexor, can help control chronic active Epstein-Barr virus disease (CAEBVD) in adults. The goal is to reduce the amount of virus in the blood and improve disease symptoms. It is for adults aged 18-70 w…
Phase: PHASE2, PHASE3 • Sponsor: Beijing Friendship Hospital • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC
-
Nerve-Sparing surgery trial aims to reduce side effects for acid reflux patients
Disease control Recruiting nowThis study is comparing two different surgical techniques for people with a hiatal hernia and severe acid reflux (GERD) that doesn't improve with medication. The goal is to see if a newer 'left-side' approach, which aims to protect a key nerve, leads to better quality of life and…
Phase: NA • Sponsor: Beijing Friendship Hospital • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
Heart risk study aims to make stomach scans safer for frail seniors
Disease control Recruiting nowThis study aims to find the safest anesthesia method for frail patients over 65 having a painless stomach exam. Researchers will compare two common sedation approaches to see which one causes fewer heart-related problems like abnormal heart rate or blood pressure. The goal is to …
Phase: NA • Sponsor: Beijing Friendship Hospital • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
New drug trial offers hope for rare, Life-Threatening immune disorder
Disease control Recruiting nowThis study is testing whether a drug called Golidocitinib can safely and effectively treat hemophagocytic lymphohistiocytosis (HLH), a rare and severe immune system disorder. It will involve 28 patients aged 14-70 who have HLH and are not currently suitable for a stem cell transp…
Phase: PHASE2, PHASE3 • Sponsor: Beijing Friendship Hospital • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
Phone app aims to cut surgery complications for stomach cancer patients
Disease control Recruiting nowThis study is testing a smartphone-based recovery program for people with stomach cancer who are getting chemotherapy before surgery. The program includes exercises and nutrition advice. Researchers want to see if using a special app helps patients stick to the plan better than s…
Phase: NA • Sponsor: Beijing Friendship Hospital • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
New hope to stop deadly clots in kidney patients
Prevention Recruiting nowThis study is testing if a newer blood thinner, rivaroxaban, is better than the standard drug warfarin at preventing dangerous blood clots in people with a specific kidney disease called idiopathic membranous nephropathy. It will enroll about 134 patients at high risk for clots b…
Phase: PHASE4 • Sponsor: Beijing Friendship Hospital • Aim: Prevention
Last updated Mar 27, 2026 12:38 UTC
-
First human test for new pill aimed at calming restless legs
Symptom relief Recruiting nowThis study is testing a new type of pill for adults with moderate to severe restless legs syndrome (RLS). Participants will take the medication twice daily for 12 weeks to see if it safely reduces the urge to move their legs and improves sleep and daily life. It's an early-stage …
Phase: PHASE1 • Sponsor: Beijing Friendship Hospital • Aim: Symptom relief
Last updated Mar 31, 2026 12:11 UTC
-
Blood test could tell doctors if rectal cancer treatment is working
Knowledge-focused Recruiting nowThis study aims to see if a personalized blood test can predict how well pre-surgery treatment works for patients with locally advanced rectal cancer. Researchers will collect blood and tissue samples from 60 patients at different times during their treatment. They will use this …
Sponsor: Beijing Friendship Hospital • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:34 UTC
-
Massive study aims to crack code on dangerous drug reactions
Knowledge-focused Recruiting nowThis study aims to understand why some people develop serious liver damage from medications or herbs while others recover. Researchers will follow 3,000 patients across China to track their recovery, identify which drugs cause the most harm, and find blood markers that can predic…
Sponsor: Beijing Friendship Hospital • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:29 UTC
-
Scientists map hidden connections between kidneys, brain, and eyes
Knowledge-focused Recruiting nowThis study aims to understand how chronic kidney disease affects the brain and eyes, not to test a treatment. Researchers will follow 1,500 adults with kidney disease for three years, using brain scans, eye imaging, and memory tests to see if changes in these organs are connected…
Sponsor: Beijing Friendship Hospital • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:14 UTC
-
Massive 4000-Patient study launched to map rare liver disease in china
Knowledge-focused Recruiting nowThis study aims to better understand primary biliary cholangitis (PBC), a chronic autoimmune liver disease, in China. Researchers will follow 4,000 patients from multiple hospitals to track their symptoms, treatments, and long-term health outcomes. The goal is to gather detailed …
Sponsor: Beijing Friendship Hospital • Aim: Knowledge-focused
Last updated Feb 25, 2026 15:07 UTC